Precision BioSciences, Inc. (DTIL) vs OptimizeRx Corp. (OPRX)

A side-by-side comparison of Precision BioSciences, Inc. and OptimizeRx Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — DTIL vs OPRX

growth of $100 · dividends reinvested · last 8y
DTIL -98.8% (-42.4%/yr)OPRX -32.2% (-4.7%/yr)OPRX compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $100202120232025$1$68
DTIL OPRX

DTIL vs OPRX: by the numbers

  • •DTIL is the larger company ($171M vs $165M market cap).
  • •OPRX is profitable (4.66% net margin) while DTIL runs a net loss (-117.04%).
  • •OPRX grew revenue faster over the past five years (13.75% vs 7.13% CAGR).

Metrics side by side

Valuation

MetricDTILOPRX
P/E ratioN/A37.71
Forward P/EN/A9.83
P/S ratio3.801.68
P/B ratio3.781.26
EV / EBITDAN/A10.41
FCF yieldN/A11.10%

Profitability

MetricDTILOPRX
Gross margin100.00%63.30%
Operating margin-152.19%11.45%
Net margin-117.04%4.66%
ROE-116.42%3.51%
ROIC-30.23%4.92%

Growth (annualized)

MetricDTILOPRX
Revenue CAGR (5Y)7.13%13.75%
Total return CAGR (5Y)-54.84%-36.23%

Frequently asked

Which has grown faster, DTIL or OPRX?
Over the past five years, OPRX grew revenue faster — DTIL at a 7.13% CAGR versus OPRX at 13.75%.
Is DTIL or OPRX more profitable?
OPRX runs the higher net margin — DTIL at -117.04% versus OPRX at 4.66%.
How have DTIL and OPRX total returns compared?
Over the past 5 years, DTIL delivered -54.84% and OPRX delivered -36.23% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.